In Harmony With Your Natural Eye
It's Additive, So Your Eye Is Still Your Eye
Unlike other procedures, EVO ICL™ is an additive procedure that doesn't require removing corneal tissue or removing your natural lens.
Embrace All That’s Natural
Similar to adding a lens to a camera, EVO ICL works with the natural parts of your eye to improve your vision so you can see the world.

Oh, And They Are Removable By a Doctor, If Desired.
EVO ICLs are removable, providing you with both flexibility and peace of mind.
It Only Takes 30 Minutes
The EVO ICL procedure is minimally invasive and the lens is implanted through a small opening, allowing for a quick procedure and recovery time. With over 3,000,000 lenses distributed worldwide, EVO ICL is quickly becoming a vision correction procedure of choice for many people around the world.
Select Your Region
Latin America
References
1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
2. Martínez-Plaza E, López-Miguel A, López-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125.
3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial. Clin Ophthalmol. 2022;16:1541-53.
4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.
5. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2321-2328.
6. Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78.